STWX:SW:SW-SPDR® MSCI Europe Health Care UCITS ETF CHF (CHF)

ETF | Others |

Last Closing

USD 199.6

Change

+1.60 (+0.81)%

Market Cap

USD 0.66B

Volume

20.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.03 (+0.23%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.07 (+0.34%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.29 (+1.07%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+65.00 (+0.81%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+43.00 (+0.82%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+17.60 (+1.07%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+13.00 (+0.57%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.21 (+0.28%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

-0.08 (-0.07%)

USD 130,595.12B

ETFs Containing STWX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.78% 73% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.78% 73% C 69% C-
Trailing 12 Months  
Capital Gain 2.52% 22% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.52% 19% F 23% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.27% 53% F 54% F
Dividend Return 5.27% 52% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.45% 65% D 69% C-
Risk Adjusted Return 81.61% 63% D 67% D+
Market Capitalization 0.66B 63% D 58% F

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike